How Do Melanoma Cells Survive Drug Treatment Long Enough to Acquire Drug Resistance?

University of Colorado Cancer Center study presented at AACR 2018 shows that even within three days of treatment, melanoma cells find a way to activate MEK - not with mutations, but with a more flexible and temporary way to allow these cancer cells to signal through the MAPK pathway even in the presence of BRAF inhibition.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News